文献速递神经肿瘤

经蝶手术质量改进项目对患者结局与医院财务绩效的影响

Effects of a transsphenoidal surgery quality improvement program on patient outcomes and hospital financial performance.
PubMed 文献 · J Neurosurg · 2021-11-19

单中心启动覆盖垂体手术后全程的全面质量改进项目,以加速出院、提升安全、减少非计划再入院为目标;回顾2015—2019年609例择期经蝶手术患者,2019年较2015年平均住院夜数缩短、术后1夜出院比例升高、30天非计划再入院率下降,人均医院利润与贡献边际增加而成本仅小幅上升。

要点

  • 2019年较2015年平均住院夜数缩短(1.6±1.0 vs 2.9±2.2夜,p<0.001)。
  • 2019年术后1夜出院比例高于2015年(75.4% vs 15.6%,p<0.001)。
  • 30天非计划再入院率由2015年8.3%降至2019年2.8%。

核心结论

  • 实施全面垂体手术质量改进项目后,患者结局显著改善、结局变异性下降、医院财务绩效提升。

研究设计与样本

  • 单中心质量改进项目,描述患者照护路径并回顾2015年1月至2019年12月所有因垂体瘤和Rathke裂囊肿接受择期经蝶手术的患者。
  • 共纳入609例由经验丰富的垂体外科医生实施择期手术的成人患者。

主要发现

  • 患者人口学、合并症和支付方构成在研究期间无显著变化(p≥0.10)。
  • 2019年较2015年平均住院夜数缩短(1.6±1.0 vs 2.9±2.2夜,p<0.001)。
  • 2019年较2015年术后1夜出院比例升高(75.4% vs 15.6%,p<0.001)。
  • 30天非计划再入院率由2015年8.3%降至2019年2.8%。
  • 人均医院利润2015年为10,613±19,321美元、2019年为18,180±21,930美元,增加71.3%;贡献边际2015年为18,925±19,236美元、2019年为26,939±22,057美元,增加42.3%;成本2015年为18,829±6611美元、2019年为19,469±4291美元,仅增加3.4%。

临床怎么用

  • 项目基础要素包括基于证据的照护路径(如低钠血症和疼痛)、院内研究项目、患者教育、预期设定、多学科团队照护、标准医嘱集、高接触出院后照护、结局审计和患者导航员等。
  • 项目目标为让多数择期患者在术后1天内出院、提升患者安全并限制非计划再入院。

局限性

  • 原文未报告局限性;作者提出未来需设计研究评估疾病缓解、患者满意度以及外科医生学习曲线与其他质量举措的协同作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: A comprehensive quality improvement (QI) program aimed at all aspects of patient care after pituitary surgery was initiated at a single center. This initiative was guided by standard quality principles to improve patient outcomes and optimize healthcare value. The programmatic goal was to discharge most elective patients within 1 day after surgery, improve patient safety, and limit unplanned readmissions. The program is described, and its effect on patient outcomes and hospital financial performance over a 5-year period are investigated. METHODS: Details of the patient care pathway are presented. Foundational elements of the QI program include evidence-based care pathways (e.g., for hyponatremia and pain), an in-house research program designed to fortify care pathways, patient education, expectation setting, multidisciplinary team care, standard order sets, high-touch postdischarge care, outcomes auditing, and a patient navigator, among other elements. Length of stay (LOS), outcome variability, 30-day unplanned readmissions, and hospital financial performance were identified as surrogate endpoints for healthcare value for the surgical epoch. To assess the effect of these protocols, all patients undergoing elective transsphenoidal surgery for pituitary tumors and Rathke's cleft cysts between January 2015 and December 2019 were reviewed. RESULTS: A total of 609 adult patients who underwent elective surgery by experienced pituitary surgeons were identified. Patient demographics, comorbidities, and payer mix did not change significantly over the study period (p ≥ 0.10). The mean LOS was significantly shorter in 2019 versus 2015 (1.6 ± 1.0 vs 2.9 ± 2.2 midnights, p < 0.001). The percentage of patients discharged after 1 midnight was significantly higher in 2019 versus 2015 (75.4% vs 15.6%, p < 0.001). The 30-day unplanned hospital readmission rate decreased to 2.8% in 2019 from 8.3% in 2015. Per-patient hospital profit increased 71.3% ($10,613 ± $19,321 in 2015; $18,180 ± $21,930 in 2019), and the contribution margin increased 42.3% ($18,925 ± $19,236 in 2015; $26,939 ± $22,057 in 2019), while costs increased by only 3.4% ($18,829 ± $6611 in 2015; $19,469 ± $4291 in 2019). CONCLUSIONS: After implementation of a comprehensive pituitary surgery QI program, patient outcomes significantly improved, outcome variability decreased, and hospital financial performance was enhanced. Future studies designed to evaluate disease remission, patient satisfaction, and how the surgeon learning curve may synergize with other quality efforts may provide additional context.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Sarris CE, Brigeman ST, Doris E, et al. Effects of a transsphenoidal surgery quality improvement program on patient outcomes and hospital financial performance. J Neurosurg. 2021. PMID: 34798599. doi:10.3171/2021.7.JNS21286

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。